# Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

> **NCT02355509** · PHASE4 · COMPLETED · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 21 (actual)

## Conditions studied

- Glucose Intolerance
- Postprandial Hyperglycemia
- Cardiovascular Risk Factor

## Interventions

- **DRUG:** Acarbose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02355509
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02355509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02355509, "Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02355509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*